EUCTR2013-004232-29-BE进行中（未招募）1 期
A phase II proof of concept study to evalute the efficacy and safety of deep subcutaneous lanreotide Autogel 120 mg / 28 days on symptoms and healing of the esophageal and gastric mucosa in patients with gastro esophageal reflux resitant to standard therapy (combination of proton pump inhibitors and H2 antagonists)
Z Brussel0 个研究点目标入组 15 人开始时间: 2013年12月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with persistent endoscopic reflux in spite of maximal medical therapy with PPI 2 x 40 mg pantoprazole before breakfast and dinner and 300 mg of H2 blocker ranitidine at bedtime AND continuing pathological reflux proven on impedancemetry.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •Pregnancy or inadequate anticonception, breast feeding.
- •Negative impedancemetry.
研究者
相似试验
进行中（未招募）
不适用
A Phase 2 Proof of Concept Study to Evaluate the Efficacy, Safety and Pharmacokinetics of the HDAC Inhibitor 4SC-201 in Patients with Relapsed or Refractory Hodgkin’s Lymphoma - SAPHIREEUCTR2009-014699-24-CZ4SC AG45
进行中（未招募）
1 期
A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa. - EVADEPrevention of nosocomial pneumonia caused by Pseudomonas aeruginosaMedDRA version: 20.0Level: LLTClassification code 10051190Term: Pneumonia Pseudomonas aeruginosaSystem Organ Class: 100000004862EUCTR2015-001706-34-HUMedImmune, LLC188
进行中（未招募）
1 期
Clinical trial looking at the safety and efficacy of MEDI3902 in the prevention of Pseudomonas aeruginosa pneumonia occurring in the hospitalPrevention of nosocomial pneumonia caused by Pseudomonas aeruginosaMedDRA version: 18.1Level: LLTClassification code 10051190Term: Pneumonia Pseudomonas aeruginosaSystem Organ Class: 100000004862EUCTR2015-001706-34-DEMedImmune, LLC429
进行中（未招募）
1 期
Clinical trial looking at the safety and efficacy of MEDI3902 in the prevention of Pseudomonas aeruginosa pneumonia occurring in the hospitalPrevention of nosocomial pneumonia caused by Pseudomonas aeruginosaMedDRA version: 20.0 Level: LLT Classification code 10051190 Term: Pneumonia Pseudomonas aeruginosa System Organ Class: 100000004862EUCTR2015-001706-34-CZMedImmune, LLC429
进行中（未招募）
1 期
Clinical trial looking at the safety and efficacy of MEDI3902 in the prevention of Pseudomonas aeruginosa pneumonia occurring in the hospitalPrevention of nosocomial pneumonia caused by Pseudomonas aeruginosaMedDRA version: 20.0 Level: LLT Classification code 10051190 Term: Pneumonia Pseudomonas aeruginosa System Organ Class: 100000041285EUCTR2015-001706-34-GRMedImmune, LLC286